Navigation Links
H. D. Smith Completes Full Ownership Acquisition Of Triplefin, Solidifying End-To-End Value Chain For Pharmaceutical And Patient Support Services
Date:9/30/2013

SPRINGFIELD, Ill., Sept. 30, 2013 /PRNewswire/ -- H. D. Smith, among the nation's largest pharmaceutical wholesalers and pharmaceutical services providers, today announced full ownership acquisition of Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services Company, headquartered in Cincinnati, Ohio. H. D. Smith secured majority representation on Triplefin's board of directors in January, 2013 and majority stock ownership interest in May, 2013. H.D. Smith has now acquired the remaining 49% of shares in Triplefin giving the Company full ownership. Triplefin will operate as a wholly owned subsidiary of H. D. Smith within the H. D. Smith Specialty Solutions Operating Unit. Financial terms of the full ownership acquisition remain confidential.

(Logo: http://photos.prnewswire.com/prnh/20121015/NY93014LOGO)

"H. D. Smith is committed to providing end-to-end value throughout the healthcare chain to our customers and the patients they serve – and the Triplefin mission to remove barriers, connect patients and grow brands fits perfectly with the H. D. Smith Specialty Solutions focus on the patient journey," said Dale Smith, chairman and executive officer, H. D. Smith. "Our interest in Triplefin began a year ago, sparked by the company's specialized offerings across patient support programs, distribution/fulfillment, marketing, pharmacy services, technology and specialty product education functions. Together, our organizations have already integrated many of our functions, and established an end-to-end service value chain touching all aspects of prescription medicine distribution and support – and we look forward to continuing to grow together." 

Together, the combined organization will continue to provide support services to traditional brand and specialty product manufacturers and pharmacy partners, including critical distribution and fulfillment functions, patient assistance and reimbursement programs, third-party logistics, pharmaceutical marketing, and product education.

"Triplefin shares the H. D. Smith Specialty Solutions commitment to supporting patients from the moment they begin receiving care, to the completion of their treatment – and together, we have the exciting opportunity to revolutionize the industry and help protect patient wellness," said Joseph Conda, president of H. D. Smith Specialty Solutions. "We remain impressed and inspired by the organization that Greg LaLonde and Rick Randall have built over the past 10 years, and we are enthusiastic about driving their mission forward – reshaping the patient journey through end-to-end solutions. That vision, and the best-in-class Triplefin services that bring it to life, are a critical part of our H. D. Smith strategic vision: to be the leader in controlling healthcare costs while maximizing patient outcomes."

About H. D. Smith

Headquartered in Springfield, Illinois, H. D. Smith is among the largest national wholesale distributors, with services and solutions for manufacturers and healthcare providers in providing products, services and care for patients nationwide. H. D. Smith has two operating units: Wholesale Distribution and Specialty Solutions. H. D. Smith Wholesale Distribution provides a complete line of prescription products, over-the-counter, health and beauty aids, home healthcare products, durable medical equipment, seasonal merchandise and a wide array of marketing programs to retail pharmacies, regional chains and health systems. Distribution facilities are located in California, Florida, Kentucky, Illinois, New Hampshire, New Jersey and Texas and serve major markets throughout the United States. In addition, H. D. Smith operates a home healthcare (HHC) distribution center in Texas; SmartSource, a generic distributor; and Valley Wholesale Drug, a regional healthcare distributor located in northern California. H. D. Smith Specialty Solutions provides end-to-end services and support programs for traditional and specialty pharmaceutical providers and patients, including specialty distribution, third-party logistics, clinical trials drug procurement, physician education, patient access, patient on-boarding and treatment, reimbursement, adherence and compliance support.    

Additional information about H. D. Smith can be found at hdsmith.com.

About Triplefin

Triplefin, a wholly owned subsidiary of H. D. Smith, is headquartered in Cincinnati, Ohio and has been recognized as a premier provider of pharmaceutical marketing support solutions. For more than 10 years, Triplefin has helped pharmaceutical brand managers remove barriers to brand access and adherence and put prescription brands into patients' hands…and keep them there throughout treatment.

Today, more than 45 pharmaceutical manufacturing companies (including 15 of the top 20), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced success with Triplefin's solutions. Our mission is to connect patients, providers, pharmacies and payers to improve outcomes and to remove brand challenges with access, acquisition and adherence.

Contact:
Mark Marmur
Makovsky + Company, Inc.
212-508-9670
mmarmur@makovsky.com

Carolyn Webb
H. D. Smith
217-747-8125
carolyn.webb@hdsmith.com


'/>"/>
SOURCE H. D. Smith
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthpoint Biotherapeutics To Assume Smith & Nephew Name
2. Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
3. GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs
4. SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc.
5. Upsher-Smith Announces Commercial Availability Of Morphine Sulfate ER Capsules
6. Upsher-Smith Teams Up With Epilepsy Foundation Of Minnesota For 2013 Stroll For Epilepsy
7. GlaxoSmithKline CFO Interviewed on Q2 Results
8. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
9. H. D. Smith Completes Acquisition Of Pharmaceutical Support Services Company Triplefin
10. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
11. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):